Santen Pharmaceutical Co Ltd R&D Day 2 Transcript
[Interpreted] We would like to begin R&D Day 2: The Future of Santen R&D.
Thank you very much for attending today despite your very busy schedule. First, let me introduce our attendees today. Satoshi Suzuki, Senior Corporate Officer and Head of Corporate Development Division and China Business; Naveed Shams, Senior Corporate Officer and Chief Scientific Officer, Head of Global R&D, Naveed Shams; Senior Vice President, Head of Biomedical and Strategy and Research, Reza Haque; Corporate Officer, Head of Pharmaceutics & Pharmacology Representative Asia R&D, Kenji Morishima; Senior Vice President, Head of Product Development, Representative, U.S. R&D, Peter Sallstig; and Shigeo Taniuchi, our President and Chief Operating Officer, is attending a conference in China. Therefore, he is not able to be here in person, but he will join us by phone to say a few words of greetings later.
My name is Takashi Matsugi, Head of R&D Strategic Operations. I will be moderating this meeting
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
